Iradimed Corp

IRMD

Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
SEC CIK: 0001325618

SEC filings (opens in a new tab)

In the last 90 days, Iradimed Corp insiders filed 0 open-market purchases and 1 sale; 213 institutions reported holding it in 13F filings for Q2 2026, worth $750.2M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Iradimed Corp changed between Q2 2021 and Q3 2021.

All holders in Q3 2021 All holders in Q2 2021

13F holders of IRMD: Q2 2021 compared with Q3 2021
Measure	Q2 2021	Q3 2021	Change
Holders	62	75	+13
Shares	4.77M	4.73M	−48.0K (−1.0%)
Value	$140.5M	$158.8M	+$18.3M (+13.0%)

New holders (17)

Institutions that held Iradimed Corp at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to IRMD in Q3 2021
Institution	Shares	Value	% of portfolio
Hillsdale Investment Management Inc.	64,400	$2.16M	0.17%
Bares Capital Management, Inc.	61,786	$2.08M	0.04%
EAM Investors, LLC	47,547	$1.60M	0.27%
Two Sigma Advisers, LP	16,800	$564.0K	0.00%
Two Sigma Investments, LP	12,251	$412.0K	0.00%
Millennium Management LLC	11,241	$378.0K	0.00%
Summit Global Investments	11,000	$369.0K	0.03%
Citadel Advisors LLC	7,086	$238.0K	0.00%
Trexquant Investment LP	6,882	$231.0K	0.02%
Captrust Financial Advisors	825	$28.0K	0.00%
US Bancorp	400	$13.0K	0.00%
Fifth Third Bancorp	283	$10.0K	0.00%
Banque Cantonale Vaudoise	200	$7.00K	0.00%
O'Shaughnessy Asset Management, LLC	52	$2.00K	0.00%
Signaturefd, LLC	49	$2.00K	0.00%
ClariVest Asset Management LLC	22	$1.00K	0.00%
Meridian Wealth Partners, LLC	8	$0	0.00%

Sold out (4)

Institutions that held Iradimed Corp at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of IRMD in Q3 2021
Institution	Shares, Q2 2021	Value, Q2 2021
Formidable Asset Management, LLC	10,000	$337.0K
Victory Capital Management Inc	5,452	$160.0K
Lazard Asset Management LLC	824	$24.0K
UBS Group AG	3	$0